Impact of Restricted Drug Coverage

Partners for Healthy Dialogues

Glossary of Terms - Rare Diseases

acquired immune deficiency syndrome (AIDS)—A manifestation of infection with the human inimunodeficiency virus (HIV) characterized by the presence of one or more opportunistic diseases which occur primarily, or in some cases only, when an individual’s immune system function is defective.

adenocarcinoma—Cancer of glandular tissue, or tumor of which gland derived cells form glandlike structures.

Rx Response Director Erin Mullen Receives Outstanding Achievement Award

New Orleans, LA (March 27, 2013) – Rx Response Director and PhRMA Associate Vice President for IT & Operations Erin Mullen, PhD., RPh, CEM, received the Outstanding Achievement Award for Preparedness at the National Hurricane Conference in New Orleans today.

Mullen was recognized for her work in transforming Rx Response from a concept to a fully operational disaster preparedness and response program that encompasses the entire bio-pharmaceutical supply system, from manufacturers to distributors to dispensers. 

Disaster Relief


On an international scale, PhRMA is engaged in the global concerns of innovation, research and development, hoping to support the discovery of new medicines for both common conditions and rare disorders.

Subscribe to our mailing list

* indicates required

Medicare Part D Pocket Card

Statement to Physician Payments Sunshine Act Final Rule

WASHINGTON, D.C. (February 1, 2013) – Pharmaceutical Research and Manufacturers of America (PhRMA) Senior Vice President Matthew Bennett issued the following statement today:

Pharmaceutical Organizations Announce Key Principles to Foster Supply Chain Security and Integrity

Washington, D.C. (January 30, 2013) The100th meeting of the National Conference of Pharmaceutical Organizations (NCPO) resolved that the member organizations will work together to help further secure the pharmaceutical supply chain.


Subscribe to RSS - Access